| pubmed-article:3592674 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:3592674 | lifeskim:mentions | umls-concept:C0030705 | lld:lifeskim |
| pubmed-article:3592674 | lifeskim:mentions | umls-concept:C1458140 | lld:lifeskim |
| pubmed-article:3592674 | lifeskim:mentions | umls-concept:C0067057 | lld:lifeskim |
| pubmed-article:3592674 | lifeskim:mentions | umls-concept:C1145667 | lld:lifeskim |
| pubmed-article:3592674 | lifeskim:mentions | umls-concept:C1709915 | lld:lifeskim |
| pubmed-article:3592674 | lifeskim:mentions | umls-concept:C2825348 | lld:lifeskim |
| pubmed-article:3592674 | pubmed:issue | 2 | lld:pubmed |
| pubmed-article:3592674 | pubmed:dateCreated | 1987-7-10 | lld:pubmed |
| pubmed-article:3592674 | pubmed:abstractText | In a patient with an unknown bleeding disorder and an IgM lambda paraproteinemia, we demonstrated by thin-layer chromatography immunostaining and enzyme-linked immunosorbent assay that this protein specifically bound to a number of glycolipids and glycoproteins which have terminal beta-galactosyl or beta-glucosyl residues. Binding to galactosylceramide or glucosylceramide was inhibited by both galactosylceramide and glucosylceramide. From these studies, it is apparent that the M-protein recognized both beta-galactosyl and beta-glucosyl residues. This M-protein was also shown to prolong the partial thromboplastin time of normal plasma. Thus, this case represents an example of anti-carbohydrate specificity of an IgM M-protein in association with a spontaneous bleeding disorder. | lld:pubmed |
| pubmed-article:3592674 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:3592674 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:3592674 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:3592674 | pubmed:language | eng | lld:pubmed |
| pubmed-article:3592674 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:3592674 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:3592674 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:3592674 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:3592674 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:3592674 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:3592674 | pubmed:month | Jun | lld:pubmed |
| pubmed-article:3592674 | pubmed:issn | 0003-9861 | lld:pubmed |
| pubmed-article:3592674 | pubmed:author | pubmed-author:YuR KRK | lld:pubmed |
| pubmed-article:3592674 | pubmed:author | pubmed-author:HardinJ AJA | lld:pubmed |
| pubmed-article:3592674 | pubmed:author | pubmed-author:RoachBB | lld:pubmed |
| pubmed-article:3592674 | pubmed:author | pubmed-author:KusunokiSS | lld:pubmed |
| pubmed-article:3592674 | pubmed:author | pubmed-author:CraftJ EJE | lld:pubmed |
| pubmed-article:3592674 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:3592674 | pubmed:volume | 255 | lld:pubmed |
| pubmed-article:3592674 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:3592674 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:3592674 | pubmed:pagination | 226-32 | lld:pubmed |
| pubmed-article:3592674 | pubmed:dateRevised | 2007-11-14 | lld:pubmed |
| pubmed-article:3592674 | pubmed:meshHeading | pubmed-meshheading:3592674-... | lld:pubmed |
| pubmed-article:3592674 | pubmed:meshHeading | pubmed-meshheading:3592674-... | lld:pubmed |
| pubmed-article:3592674 | pubmed:meshHeading | pubmed-meshheading:3592674-... | lld:pubmed |
| pubmed-article:3592674 | pubmed:meshHeading | pubmed-meshheading:3592674-... | lld:pubmed |
| pubmed-article:3592674 | pubmed:meshHeading | pubmed-meshheading:3592674-... | lld:pubmed |
| pubmed-article:3592674 | pubmed:meshHeading | pubmed-meshheading:3592674-... | lld:pubmed |
| pubmed-article:3592674 | pubmed:meshHeading | pubmed-meshheading:3592674-... | lld:pubmed |
| pubmed-article:3592674 | pubmed:meshHeading | pubmed-meshheading:3592674-... | lld:pubmed |
| pubmed-article:3592674 | pubmed:meshHeading | pubmed-meshheading:3592674-... | lld:pubmed |
| pubmed-article:3592674 | pubmed:meshHeading | pubmed-meshheading:3592674-... | lld:pubmed |
| pubmed-article:3592674 | pubmed:meshHeading | pubmed-meshheading:3592674-... | lld:pubmed |
| pubmed-article:3592674 | pubmed:meshHeading | pubmed-meshheading:3592674-... | lld:pubmed |
| pubmed-article:3592674 | pubmed:year | 1987 | lld:pubmed |
| pubmed-article:3592674 | pubmed:articleTitle | A human IgM M-protein in a patient with unknown bleeding disorder binds to beta-galactosyl and beta-glucosyl residues. | lld:pubmed |
| pubmed-article:3592674 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:3592674 | pubmed:publicationType | Research Support, U.S. Gov't, P.H.S. | lld:pubmed |
| pubmed-article:3592674 | pubmed:publicationType | Case Reports | lld:pubmed |
| pubmed-article:3592674 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
